tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
enGene Secures Expanded $125 Million Debt Facility to Advance Bladder Cancer Gene Therapy
PremiumCompany AnnouncementsenGene Secures Expanded $125 Million Debt Facility to Advance Bladder Cancer Gene Therapy
16d ago
3 ‘Strong Buy’ Stocks to Buy Today,12/26/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/26/2025, According to Top Analysts
1M ago
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
Premium
Market News
3 ‘Strong Buy’ Stocks to Buy Today,12/24/2025, According to Top Analysts
1M ago
Strong Buy Rating for enGene Driven by Regulatory Advancements and Market Readiness of Detalimogene
PremiumRatingsStrong Buy Rating for enGene Driven by Regulatory Advancements and Market Readiness of Detalimogene
2M ago
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program
Premium
Company Announcements
enGene’s Detalimogene Chosen for FDA Manufacturing Pilot Program
2M ago
enGene detalimogene voraplasmid selected for FDA manufacturing pilot program
Premium
The Fly
enGene detalimogene voraplasmid selected for FDA manufacturing pilot program
2M ago
enGene Holdings Announces Public Offering of Common Shares
PremiumCompany AnnouncementsenGene Holdings Announces Public Offering of Common Shares
3M ago
enGene announves common shares offering, no amount given
Premium
The Fly
enGene announves common shares offering, no amount given
3M ago
enGene price target raised to $19 from $18 at Morgan Stanley
Premium
The Fly
enGene price target raised to $19 from $18 at Morgan Stanley
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100